{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:36:23Z","timestamp":1793702183344,"version":"4.5.1"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13300-023-01431-3","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T22:01:46Z","timestamp":1686866506000},"page":"1241-1266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type\u00a01 Disease"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-4079","authenticated-orcid":false,"given":"Tomasz","family":"Klupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Czupryniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Dzida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslawa","family":"Jarosz-Chobot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Gumprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mysliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szadkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Bomba-Opon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Malecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota A.","family":"Zozulinska-Ziolkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1932296818812062","volume":"13","author":"G Freckmann","year":"2019","unstructured":"Freckmann G, Pleus S, Grady M, Setford S, Levy B. Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices. J Diabetes Sci Technol. 2019;13:575\u201383. https:\/\/doi.org\/10.1177\/1932296818812062.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1089\/dia.2014.0378","volume":"17","author":"T Bailey","year":"2015","unstructured":"Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17:787\u201394. https:\/\/doi.org\/10.1089\/dia.2014.0378.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1479164118756240","volume":"15","author":"RA Ajjan","year":"2018","unstructured":"Ajjan RA, Cummings MH, Jennings P, Leelarathna L, Rayman G, Wilmot EG. Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice. Diabetes Vasc Dis Re. 2018;15:175\u201384. https:\/\/doi.org\/10.1177\/1479164118756240.","journal-title":"Diabetes Vasc Dis Re"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/dia.2018.0142","volume":"20","author":"SK Garg","year":"2018","unstructured":"Garg SK, Akturk HK. A new era in continuous glucose monitoring: food and drug administration creates a new category of factory-calibrated nonadjunctive, interoperable class II medical devices. Diabetes Technol Ther. 2018;20:391\u20134. https:\/\/doi.org\/10.1089\/dia.2018.0142.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/dia.2021.0236","volume":"23","author":"TS Bailey","year":"2021","unstructured":"Bailey TS, Alva S. Landscape of continuous glucose monitoring (CGM) and integrated CGM: accuracy considerations. Diabetes Technol Ther. 2021;23:5\u201311. https:\/\/doi.org\/10.1089\/dia.2021.0236.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820958754","author":"S Alva","year":"2020","unstructured":"Alva S, Bailey T, Brazg R, et al. Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes. J Diabetes Sci Technol. 2020. https:\/\/doi.org\/10.1177\/1932296820958754.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1932296820911919","volume":"15","author":"JI Joseph","year":"2021","unstructured":"Joseph JI. Review of the long-term implantable senseonics continuous glucose monitoring system and other continuous glucose monitoring systems. J Diabetes Sci Technol. 2021;15:167\u201373. https:\/\/doi.org\/10.1177\/1932296820911919.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1089\/dia.2018.0143","volume":"20","author":"VN Shah","year":"2018","unstructured":"Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther. 2018;20:428\u201333. https:\/\/doi.org\/10.1089\/dia.2018.0143.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/dia.2021.0014","volume":"23","author":"J van der Linden","year":"2021","unstructured":"van der Linden J, Welsh JB, Walker TC. Sustainable use of a real-time continuous glucose monitoring system from 2018 to 2020. Diabetes Technol Ther. 2021;23:508\u201311. https:\/\/doi.org\/10.1089\/dia.2021.0014.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/s41598-019-42555-6","volume":"9","author":"KV Raviteja","year":"2019","unstructured":"Raviteja KV, Kumar R, Dayal D, Sachdeva N. Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type\u00a01 diabetes mellitus: an open-label randomized control trial. Sci Rep. 2019;9:6120. https:\/\/doi.org\/10.1038\/s41598-019-42555-6.","journal-title":"Sci Rep"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2016.19976","volume":"317","author":"M Lind","year":"2017","unstructured":"Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type\u00a01 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA. 2017;317:379\u201387. https:\/\/doi.org\/10.1001\/jama.2016.19976.","journal-title":"JAMA"},{"key":"1431_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2337\/dc16-2482","volume":"40","author":"G Aleppo","year":"2017","unstructured":"Aleppo G, Ruedy KJ, Riddlesworth TD, et al. REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type\u00a01 diabetes. Diabetes Care. 2017;40:538\u201345. https:\/\/doi.org\/10.2337\/dc16-2482.","journal-title":"Diabetes Care"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type\u00a01 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371\u20138. https:\/\/doi.org\/10.1001\/jama.2016.19975.","journal-title":"JAMA"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2337\/dc19-0888","volume":"43","author":"J \u0160oupal","year":"2019","unstructured":"\u0160oupal J, Petru\u017eelkov\u00e1 L, Grunberger G, et al. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study. Diabetes Care. 2019;43:37\u201343. https:\/\/doi.org\/10.2337\/dc19-0888.","journal-title":"Diabetes Care"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/pedi.12735","volume":"19","author":"FM Campbell","year":"2018","unstructured":"Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type\u00a01 diabetes in a single arm study. Pediatr Diabetes. 2018;19:1294\u2013301. https:\/\/doi.org\/10.1111\/pedi.12735.","journal-title":"Pediatr Diabetes"},{"key":"1431_CR16","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2205650","author":"L Leelarathna","year":"2022","unstructured":"Leelarathna L, Evans ML, Neupane S, et al. Intermittently scanned continuous glucose monitoring for type\u00a01 diabetes. New Engl J Med. 2022. https:\/\/doi.org\/10.1056\/nejmoa2205650.","journal-title":"New Engl J Med"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","volume":"55","author":"T Battelino","year":"2012","unstructured":"Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type\u00a01 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155\u201362. https:\/\/doi.org\/10.1007\/s00125-012-2708-9.","journal-title":"Diabetologia"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/dc09-1502","volume":"33","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2010","unstructured":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010;33:17\u201322. https:\/\/doi.org\/10.2337\/dc09-1502.","journal-title":"Diabetes Care"},{"key":"1431_CR19","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2021.7444","volume":"325","author":"T Martens","year":"2021","unstructured":"Martens T, Beck RW, Bailey R, et al. Effect of continuous glucose monitoring on glycemic control in patients with type\u00a02 diabetes treated with basal insulin. JAMA. 2021;325:2262\u201372. https:\/\/doi.org\/10.1001\/jama.2021.7444.","journal-title":"JAMA"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/m16-2855","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type\u00a02 diabetes receiving multiple daily insulin injections. Ann Intern Med. 2017;167:365. https:\/\/doi.org\/10.7326\/m16-2855.","journal-title":"Ann Intern Med"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/ds20-0069","volume":"34","author":"EE Wright","year":"2021","unstructured":"Wright EE, Kerr MSD, Reyes IJ, Nabutovsky Y, Miller E. Use of flash continuous glucose monitoring is associated with A1C reduction in people with type\u00a02 diabetes treated with basal insulin or noninsulin therapy. Diabetes Spectr. 2021;34:184\u20139. https:\/\/doi.org\/10.2337\/ds20-0069.","journal-title":"Diabetes Spectr"},{"key":"1431_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001115","volume":"8","author":"E Wada","year":"2020","unstructured":"Wada E, Onoue T, Kobayashi T, et al. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type\u00a02 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2020;8:e001115. https:\/\/doi.org\/10.1136\/bmjdrc-2019-001115.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s13300-017-0281-4","volume":"8","author":"T Riddlesworth","year":"2017","unstructured":"Riddlesworth T, Price D, Cohen N, Beck RW. Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type\u00a01 diabetes using multiple daily insulin injections. Diabetes Ther. 2017;8:947\u201351. https:\/\/doi.org\/10.1007\/s13300-017-0281-4.","journal-title":"Diabetes Ther"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/s0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type\u00a01 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(16)31535-5.","journal-title":"Lancet"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type\u00a02 diabetes: a multicenter open-label randomized controlled trial. Diabetes Ther. 2017;8:55\u201373. https:\/\/doi.org\/10.1007\/s13300-016-0223-6.","journal-title":"Diabetes Ther"},{"key":"1431_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2337\/dc21-2004","volume":"45","author":"A Champakanath","year":"2022","unstructured":"Champakanath A, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Continuous glucose monitoring initiation within first year of type\u00a01 diabetes diagnosis is associated with improved glycemic outcomes: 7-year follow-up study. Diabetes Care. 2022;45:750\u20133. https:\/\/doi.org\/10.2337\/dc21-2004.","journal-title":"Diabetes Care"},{"key":"1431_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-022-01253-9","author":"M Evans","year":"2022","unstructured":"Evans M, Welsh Z, Seibold A. Reductions in HbA1c with flash glucose monitoring are sustained for up to 24 months: a meta-analysis of 75 real-world observational studies. Diabetes Ther. 2022. https:\/\/doi.org\/10.1007\/s13300-022-01253-9.","journal-title":"Diabetes Ther"},{"key":"1431_CR28","doi-asserted-by":"publisher","unstructured":"Agiostratidou G, Anhalt H, Ball D, et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type\u00a01 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017;40:1622\u201330. https:\/\/doi.org\/10.2337\/dc17-1624.","DOI":"10.2337\/dc17-1624"},{"key":"1431_CR29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631\u201340. https:\/\/doi.org\/10.2337\/dc17-1600.","journal-title":"Diabetes Care"},{"key":"1431_CR30","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019. https:\/\/doi.org\/10.2337\/dci19-0028.","journal-title":"Diabetes Care"},{"key":"1431_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/dia.2021.0374","volume":"24","author":"RW Beck","year":"2022","unstructured":"Beck RW, Bergenstal RM. Continuous glucose monitoring for type\u00a02 diabetes: how does it compare with type\u00a01 diabetes? Diabetes Technol Ther. 2022;24:153\u20136. https:\/\/doi.org\/10.1089\/dia.2021.0374.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.108106","volume":"36","author":"RM Bergenstal","year":"2022","unstructured":"Bergenstal RM, Mullen DM, Strock E, Johnson ML, Xi MX. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type\u00a02 diabetes. J Diabetes Complicat. 2022;36: 108106. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108106.","journal-title":"J Diabetes Complicat"},{"key":"1431_CR33","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.3390\/ijerph18063123","volume":"18","author":"A D\u00edez-Fern\u00e1ndez","year":"2021","unstructured":"D\u00edez-Fern\u00e1ndez A, Rodr\u00edguez-Huerta MD, Mir\u00f3n-Gonz\u00e1lez R, Laredo-Aguilera JA, Mart\u00edn-Espinosa NM. Flash glucose monitoring and patient satisfaction: a meta-review of systematic reviews. Int J Environ Res Pu. 2021;18:3123. https:\/\/doi.org\/10.3390\/ijerph18063123.","journal-title":"Int J Environ Res Pu"},{"key":"1431_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/dia.2020.0666","volume":"23","author":"TR Gilbert","year":"2021","unstructured":"Gilbert TR, Noar A, Blalock O, Polonsky WH. Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. Diabetes Technol Ther. 2021;23:35\u20139. https:\/\/doi.org\/10.1089\/dia.2020.0666.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2337\/dc17-0133","volume":"40","author":"WH Polonsky","year":"2017","unstructured":"Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type\u00a01 diabetes: further findings from the diamond randomized clinical trial. Diabetes Care. 2017;40:170. https:\/\/doi.org\/10.2337\/dc17-0133.","journal-title":"Diabetes Care"},{"key":"1431_CR36","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/jc.2017-02498","volume":"103","author":"S Charleer","year":"2018","unstructured":"Charleer S, Mathieu C, Nobels F, et al. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab. 2018;103:1224\u201332. https:\/\/doi.org\/10.1210\/jc.2017-02498.","journal-title":"J Clin Endocrinol Metab"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc19-1610","volume":"43","author":"S Charleer","year":"2020","unstructured":"Charleer S, Block CD, Huffel LV, et al. Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type\u00a01 diabetes (FUTURE): a prospective observational real-world cohort study. Diabetes Care. 2020;43:389\u201397. https:\/\/doi.org\/10.2337\/dc19-1610.","journal-title":"Diabetes Care"},{"key":"1431_CR38","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1690","author":"R Roussel","year":"2021","unstructured":"Roussel R, Riveline J-P, Vicaut E, et al. Important drop rate of acute diabetes complications in people with type\u00a01 or type\u00a02 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care. 2021. https:\/\/doi.org\/10.2337\/dc20-1690.","journal-title":"Diabetes Care"},{"key":"1431_CR39","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0085","author":"J-P Riveline","year":"2022","unstructured":"Riveline J-P, Roussel R, Vicaut E, et al. Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther. 2022. https:\/\/doi.org\/10.1089\/dia.2022.0085.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR40","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0271","author":"B Guerci","year":"2022","unstructured":"Guerci B, Roussel R, Levrat-Guillen F, et al. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre\u00ae system initiation in people with type\u00a02 diabetes on basal insulin therapy in France. Diabetes Technol Ther. 2022. https:\/\/doi.org\/10.1089\/dia.2022.0271.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR41","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1932296816645365","volume":"10","author":"K Barnard","year":"2016","unstructured":"Barnard K, Crabtree V, Adolfsson P, et al. Impact of type\u00a01 diabetes technology on family members\/significant others of people with diabetes. J Diabetes Sci Technol. 2016;10:824\u201330. https:\/\/doi.org\/10.1177\/1932296816645365.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070477","volume":"13","author":"L Beasant","year":"2023","unstructured":"Beasant L, Cullen F, Thomas E, et al. Flash glucose monitoring in young people with type\u00a01 diabetes\u2014a qualitative study of young people, parents and health professionals: \u2018it makes life much easier.\u2019 BMJ Open. 2023;13:e070477. https:\/\/doi.org\/10.1136\/bmjopen-2022-070477.","journal-title":"BMJ Open"},{"key":"1431_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/dme.14188","volume":"37","author":"SE Boucher","year":"2020","unstructured":"Boucher SE, Aum SH, Crocket HR, et al. Exploring parental perspectives after commencement of flash glucose monitoring for type\u00a01 diabetes in adolescents and young adults not meeting glycaemic targets: a qualitative study. Diabet Med. 2020;37:657\u201364. https:\/\/doi.org\/10.1111\/dme.14188.","journal-title":"Diabet Med"},{"key":"1431_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/dia.2018.0347","volume":"21","author":"SM Ng","year":"2019","unstructured":"Ng SM, Moore HS, Clemente MF, Pintus D, Soni A. Continuous glucose monitoring in children with type\u00a01 diabetes improves well-being, alleviates worry and fear of hypoglycemia. Diabetes Technol Ther. 2019;21:133\u20137. https:\/\/doi.org\/10.1089\/dia.2018.0347.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1210\/jendso\/bvad021","volume":"7","author":"SM Ng","year":"2023","unstructured":"Ng SM, Dearman S, Fisher M, Mushtaq T, Randell T. Paediatric society and hyperinsulinism charity national surveys on CGM access for patients with recurrent hypoglycaemia. J Endocr Soc. 2023;7:21. https:\/\/doi.org\/10.1210\/jendso\/bvad021.","journal-title":"J Endocr Soc"},{"key":"1431_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032037","volume":"9","author":"K Mattishent","year":"2019","unstructured":"Mattishent K, Lane K, Salter C, et al. Continuous glucose monitoring in older people with diabetes and memory problems: a mixed-methods feasibility study in the UK. BMJ Open. 2019;9:e032037. https:\/\/doi.org\/10.1136\/bmjopen-2019-032037.","journal-title":"BMJ Open"},{"key":"1431_CR47","doi-asserted-by":"publisher","DOI":"10.2196\/35687","volume":"7","author":"NA Allen","year":"2022","unstructured":"Allen NA, Litchman ML, Chamberlain J, Grigorian EG, Iacob E, Berg CA. Continuous glucose monitoring data sharing in older adults with type\u00a01 diabetes: pilot intervention study. JMIR Diabetes. 2022;7:e35687. https:\/\/doi.org\/10.2196\/35687.","journal-title":"JMIR Diabetes"},{"key":"1431_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820978423","author":"WH Polonsky","year":"2020","unstructured":"Polonsky WH, Fortmann AL. Impact of real-time CGM data sharing on quality of life in the caregivers of adults and children with type\u00a01 diabetes. J Diabetes Sci Technol. 2020. https:\/\/doi.org\/10.1177\/1932296820978423.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(22)00319-9","author":"T Battelino","year":"2022","unstructured":"Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2022. https:\/\/doi.org\/10.1016\/s2213-8587(22)00319-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1431_CR50","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/193229681300700408","volume":"7","author":"BD Mensh","year":"2013","unstructured":"Mensh BD, Wisniewski NA, Neil BM, Burnett DR. Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol. 2013;7:863\u201370. https:\/\/doi.org\/10.1177\/193229681300700408.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-012-0001-0","volume":"6","author":"J Schabert","year":"2013","unstructured":"Schabert J, Browne JL, Mosely K, Speight J. Social stigma in diabetes: a framework to understand a growing problem for an increasing epidemic. Patient. 2013;6:1\u201310. https:\/\/doi.org\/10.1007\/s40271-012-0001-0.","journal-title":"Patient"},{"key":"1431_CR52","unstructured":"FreeStyle Libre for glucose monitoring. Medtech innovation briefing [MIB110] 2017."},{"key":"1431_CR53","unstructured":"Type 1 diabetes in adults: diagnosis and management NICE guideline Published: 26 August 2015. Last updated: 17 August 2022. https:\/\/www.nice.org.uk\/guidance\/ng17."},{"key":"1431_CR54","unstructured":"Type 2 diabetes in adults: management NICE guideline. Published: 2 December 2015. Last updated: 29 June 2022. https:\/\/www.nice.org.uk\/guidance\/ng28."},{"key":"1431_CR55","unstructured":"Diabetes (type 1 and type 2) in children and young people: diagnosis and management NICE guideline. Published: 1 August 2015. Last updated: 11 May 2023. https:\/\/www.nice.org.uk\/guidance\/ng18."},{"key":"1431_CR56","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes\u20142019. Diabetes Care 2018;42:71\u201380. https:\/\/doi.org\/10.2337\/dc19-s007.","DOI":"10.2337\/dc19-s007"},{"key":"1431_CR57","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, et al. 7. Diabetes Technology: Standards of Medical Care in Diabetes\u20142022. Diabetes Care 2021;45:S97\u2013112. https:\/\/doi.org\/10.2337\/dc22-s007.","DOI":"10.2337\/dc22-s007"},{"key":"1431_CR58","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type\u00a01 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44:2589\u2013625. https:\/\/doi.org\/10.2337\/dci21-0043.","journal-title":"Diabetes Care"},{"key":"1431_CR59","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/pedi.13451","volume":"23","author":"M Tauschmann","year":"2022","unstructured":"Tauschmann M, Forlenza G, Hood K, et al. ISPAD clinical practice consensus guidelines 2022: diabetes technologies: glucose monitoring. Pediatr Diabetes. 2022;23:1390\u2013405. https:\/\/doi.org\/10.1111\/pedi.13451.","journal-title":"Pediatr Diabetes"},{"key":"1431_CR60","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/pedi.13455","volume":"23","author":"M Bock","year":"2022","unstructured":"Bock M, Codner E, Craig ME, et al. ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23:1270\u20136. https:\/\/doi.org\/10.1111\/pedi.13455.","journal-title":"Pediatr Diabetes"},{"key":"1431_CR61","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/pedi.13456","volume":"23","author":"A Virmani","year":"2022","unstructured":"Virmani A, Brink SJ, Middlehurst A, et al. ISPAD Clinical Practice Consensus Guidelines 2022: management of the child, adolescent, and young adult with diabetes in limited resource settings. Pediatr Diabetes. 2022;23:1529\u201351. https:\/\/doi.org\/10.1111\/pedi.13456.","journal-title":"Pediatr Diabetes"},{"key":"1431_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13410","author":"REJ Besser","year":"2022","unstructured":"Besser REJ, Bell KJ, Couper JJ, et al. Stages of type\u00a01 diabetes in children and adolescents. Pediatr Diabetes. 2022. https:\/\/doi.org\/10.1111\/pedi.13410.","journal-title":"Pediatr Diabetes"},{"key":"1431_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05787-2","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type\u00a02 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022. https:\/\/doi.org\/10.1007\/s00125-022-05787-2.","journal-title":"Diabetologia"},{"key":"1431_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","volume":"27","author":"G Grunberger","year":"2021","unstructured":"Grunberger G, Sherr J, Allende M, et al. American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021;27:505\u201337. https:\/\/doi.org\/10.1016\/j.eprac.2021.04.008.","journal-title":"Endocr Pract"},{"key":"1431_CR65","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.eprac.2021.07.006","volume":"27","author":"N Virdi","year":"2021","unstructured":"Virdi N. Response to American Association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021;27:1062. https:\/\/doi.org\/10.1016\/j.eprac.2021.07.006.","journal-title":"Endocr Pract"},{"key":"1431_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110718","author":"APK Kong","year":"2023","unstructured":"Kong APK, Lim S, Yoo SH, et al. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management. Diabetes Res Clin Pract. 2023. https:\/\/doi.org\/10.1016\/j.diabres.2023.110718.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR67","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/dia.2007.0302","volume":"10","author":"JDRF CGM Study Group","year":"2008","unstructured":"JDRF CGM Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type\u00a01 diabetes: research design and methods. Diabetes Technol Ther. 2008;10:310\u201321. https:\/\/doi.org\/10.1089\/dia.2007.0302.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818822539","author":"R Ziegler","year":"2019","unstructured":"Ziegler R, von Sengbusch S, Kr\u00f6ger J, et al. Therapy adjustments based on trend arrows using continuous glucose monitoring systems. J Diabetes Sci Technol. 2019. https:\/\/doi.org\/10.1177\/1932296818822539.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jdiacomp.2005.08.005","volume":"20","author":"K Akram","year":"2006","unstructured":"Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycemia in insulin-treated type\u00a02 diabetes: a literature survey. J Diabetes Complicat. 2006;20:402\u20138. https:\/\/doi.org\/10.1016\/j.jdiacomp.2005.08.005.","journal-title":"J Diabetes Complicat"},{"key":"1431_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002590","volume":"10","author":"AL Carlson","year":"2022","unstructured":"Carlson AL, Daniel TD, DeSantis A, et al. Flash glucose monitoring in type\u00a02 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis. BMJ Open Diabetes Res Care. 2022;10:e002590. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002590.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1431_CR71","doi-asserted-by":"publisher","first-page":"372","DOI":"10.37765\/ajmc.2021.88780","volume":"27","author":"E Miller","year":"2021","unstructured":"Miller E, Kerr MSD, Roberts GJ, Nabutovsky Y, Wright E. Flash CGM associated with event reduction in nonintensive diabetes therapy. Am J Manag Care. 2021;27:372\u20137. https:\/\/doi.org\/10.37765\/ajmc.2021.88780.","journal-title":"Am J Manag Care"},{"key":"1431_CR72","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/1932296820905577","volume":"15","author":"R Ziegler","year":"2021","unstructured":"Ziegler R, Heinemann L, Freckmann G, Schnell O, Hinzmann R, Kulzer B. Intermittent use of continuous glucose monitoring: expanding the clinical value of CGM. J Diabetes Sci Technol. 2021;15:684\u201394. https:\/\/doi.org\/10.1177\/1932296820905577.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jdi.12807","volume":"9","author":"PJ Taylor","year":"2018","unstructured":"Taylor PJ, Thompson CH, Brinkworth GD. Effectiveness and acceptability of continuous glucose monitoring for type\u00a02 diabetes management: a narrative review. J Diabetes Invest. 2018;9:713\u201325. https:\/\/doi.org\/10.1111\/jdi.12807.","journal-title":"J Diabetes Invest"},{"key":"1431_CR74","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s13300-021-01086-y","volume":"12","author":"DA Price","year":"2021","unstructured":"Price DA, Deng Q, Kipnes M, Beck SE. Episodic real-time CGM use in adults with type\u00a02 diabetes: results of a pilot randomized controlled trial. Diabetes Ther. 2021;12:2089\u201399. https:\/\/doi.org\/10.1007\/s13300-021-01086-y.","journal-title":"Diabetes Ther"},{"key":"1431_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14852","author":"SJ Moon","year":"2022","unstructured":"Moon SJ, Kim K, Lee WJ, Lee MY, Vigersky R, Park C. Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type\u00a02 diabetes: a randomized controlled trial. Diabetes Obes Metab. 2022. https:\/\/doi.org\/10.1111\/dom.14852.","journal-title":"Diabetes Obes Metab"},{"key":"1431_CR76","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.diabres.2008.01.006","volume":"80","author":"NA Allen","year":"2008","unstructured":"Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type\u00a02 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2008;80:371\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2008.01.006.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR77","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/1932296815581052","volume":"9","author":"RR Gehlaut","year":"2015","unstructured":"Gehlaut RR, Dogbey GY, Schwartz FL, Marling CR, Shubrook JH. Hypoglycemia in type\u00a02 diabetes\u2014more common than you think. J Diabetes Sci Technol. 2015;9:999\u20131005. https:\/\/doi.org\/10.1177\/1932296815581052.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR78","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/dme.13924","volume":"36","author":"P Choudhary","year":"2019","unstructured":"Choudhary P, Portu S, Delbaere A, Lyon J, Pickup JC. A modelling study of the budget impact of improved glycaemic control in adults with type\u00a01 diabetes in the UK. Diabetic Med. 2019;36:988\u201394. https:\/\/doi.org\/10.1111\/dme.13924.","journal-title":"Diabetic Med"},{"key":"1431_CR79","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2341","author":"MA Rotondi","year":"2022","unstructured":"Rotondi MA, Wong O, Riddell M, Perkins B. Population-level impact and cost-effectiveness of continuous glucose monitoring and intermittently scanned continuous glucose monitoring technologies for adults with type\u00a01 diabetes in Canada: a modeling study. Diabetes Care. 2022. https:\/\/doi.org\/10.2337\/dc21-2341.","journal-title":"Diabetes Care"},{"key":"1431_CR80","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13300-020-00959-y","volume":"12","author":"S Roze","year":"2021","unstructured":"Roze S, Isitt JJ, Smith-Palmer J, et al. Long-term cost-effectiveness the Dexcom G6 real-time continuous glucose monitoring system compared with self-monitoring of blood glucose in people with type\u00a01 diabetes in France. Diabetes Ther. 2021;12:235\u201346. https:\/\/doi.org\/10.1007\/s13300-020-00959-y.","journal-title":"Diabetes Ther"},{"key":"1431_CR81","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.2337\/dc19-2213","volume":"43","author":"S Roze","year":"2020","unstructured":"Roze S, Isitt J, Smith-Palmer J, Javanbakht M, Lynch P. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring versus self-monitoring of blood glucose in patients with type\u00a01 diabetes in the UK. Diabetes Care. 2020;43:2411\u20137. https:\/\/doi.org\/10.2337\/dc19-2213.","journal-title":"Diabetes Care"},{"key":"1431_CR82","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/1932296816628547","volume":"10","author":"SJ Fonda","year":"2016","unstructured":"Fonda SJ, Graham C, Munakata J, Powers JM, Price D, Vigersky RA. The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type\u00a02 diabetes. J Diabetes Sci Technol. 2016;10:898\u2013904. https:\/\/doi.org\/10.1177\/1932296816628547.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR83","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/13696998.2017.1390474","volume":"21","author":"JA Sierra","year":"2018","unstructured":"Sierra JA, Shah M, Gill MS, et al. Clinical and economic benefits of professional CGM among people with type\u00a02 diabetes in the United States: analysis of claims and lab data. J Med Econ. 2018;21:225\u201330. https:\/\/doi.org\/10.1080\/13696998.2017.1390474.","journal-title":"J Med Econ"},{"key":"1431_CR84","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0166","author":"M Yaron","year":"2019","unstructured":"Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type\u00a02 diabetes. Diabetes Care. 2019. https:\/\/doi.org\/10.2337\/dc18-0166.","journal-title":"Diabetes Care"},{"key":"1431_CR85","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361\u20139. https:\/\/doi.org\/10.1016\/s2213-8587(18)30051-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1431_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005143","volume":"16","author":"H Hall","year":"2018","unstructured":"Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. Plos Biol. 2018;16:e2005143. https:\/\/doi.org\/10.1371\/journal.pbio.2005143.","journal-title":"Plos Biol"},{"key":"1431_CR87","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s11606-007-0433-8","volume":"22","author":"MM Safford","year":"2007","unstructured":"Safford MM, Shewchuk R, Qu H, et al. Reasons for not intensifying medications: differentiating \u201cclinical inertia\u201d from appropriate care. J Gen Intern Med. 2007;22:1648\u201355. https:\/\/doi.org\/10.1007\/s11606-007-0433-8.","journal-title":"J Gen Intern Med"},{"key":"1431_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12626","author":"K Khunti","year":"2016","unstructured":"Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia in intensifying therapy among people with type\u00a02 diabetes treated with basal insulin. Diabetes Obes Metab. 2016. https:\/\/doi.org\/10.1111\/dom.12626.","journal-title":"Diabetes Obes Metab"},{"key":"1431_CR89","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pcd.2017.09.001","volume":"12","author":"S Seidu","year":"2018","unstructured":"Seidu S, Than T, Kar D, et al. Therapeutic inertia amongst general practitioners with interest in diabetes. Prim Care Diabetes. 2018;12:87\u201391. https:\/\/doi.org\/10.1016\/j.pcd.2017.09.001.","journal-title":"Prim Care Diabetes"},{"key":"1431_CR90","doi-asserted-by":"publisher","first-page":"813","DOI":"10.7326\/m20-2470","volume":"173","author":"K Doyle-Delgado","year":"2020","unstructured":"Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic approaches to glycemic treatment of type\u00a02 diabetes: synopsis of the 2020 American Diabetes Association\u2019s standards of medical care in diabetes clinical guideline. Ann Intern Med. 2020;173:813\u201321. https:\/\/doi.org\/10.7326\/m20-2470.","journal-title":"Ann Intern Med"},{"key":"1431_CR91","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/dom.13088","volume":"20","author":"K Khunti","year":"2018","unstructured":"Khunti K, Gomes MB, Pocock S, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type\u00a02 diabetes: a systematic review. Diabetes Obes Metab. 2018;20:427\u201337. https:\/\/doi.org\/10.1111\/dom.13088.","journal-title":"Diabetes Obes Metab"},{"key":"1431_CR92","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/healthcare10091673","volume":"10","author":"P Kaewbut","year":"2022","unstructured":"Kaewbut P, Kosachunhanun N, Phrommintikul A, Chinwong D, Hall JJ, Chinwong S. Time to treatment intensification to reduce diabetes-related complications: a post hoc study. Healthcare (Basel). 2022;10:1673. https:\/\/doi.org\/10.3390\/healthcare10091673.","journal-title":"Healthcare (Basel)"},{"key":"1431_CR93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-015-0260-x","volume":"14","author":"SK Paul","year":"2015","unstructured":"Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type\u00a02 diabetes. Cardiovasc Diabetol. 2015;14:100. https:\/\/doi.org\/10.1186\/s12933-015-0260-x.","journal-title":"Cardiovasc Diabetol"},{"key":"1431_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2019.1645018","volume":"23","author":"SC Bain","year":"2019","unstructured":"Bain SC, Hansen BB, Hunt B, Chubb B, Valentine WJ. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type\u00a02 diabetes in the UK. J Med Econ. 2019;23:1\u20131. https:\/\/doi.org\/10.1080\/13696998.2019.1645018.","journal-title":"J Med Econ"},{"key":"1431_CR95","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2022-0110","author":"F Tsotra","year":"2022","unstructured":"Tsotra F, Kappel M, Peristeris P, et al. The societal impact of early intensified treatment in patients with type\u00a02 diabetes mellitus. J Comp Effect Res. 2022. https:\/\/doi.org\/10.2217\/cer-2022-0110.","journal-title":"J Comp Effect Res"},{"key":"1431_CR96","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","volume":"28","author":"WH Polonsky","year":"2005","unstructured":"Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type\u00a02 diabetes. Diabetes Care. 2005;28:2543\u20135. https:\/\/doi.org\/10.2337\/diacare.28.10.2543.","journal-title":"Diabetes Care"},{"key":"1431_CR97","doi-asserted-by":"crossref","unstructured":"Harris S, Levrat-Guillen F. Use of the FreeStyle Libre\u00ae system in diabetes treatment for people with T2D: results from a retrospective cohort study using Canadian private payer claims database. Diabetes Obesity Metab. 2023:25(6):1704\u201313.","DOI":"10.1111\/dom.15025"},{"key":"1431_CR98","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/1932296821998724","volume":"15","author":"GD Simonson","year":"2021","unstructured":"Simonson GD, Bergenstal RM, Johnson ML, Davidson JL, Martens TW. Effect of professional CGM (pCGM) on glucose management in type\u00a02 diabetes patients in primary care. J Diabetes Sci Technol. 2021;15:539\u201345. https:\/\/doi.org\/10.1177\/1932296821998724.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR99","doi-asserted-by":"publisher","unstructured":"Sherrill CH, Houpt CT, Dixon EM, Richter SJ. Effect of pharmacist-driven professional continuous glucose monitoring in adults with uncontrolled diabetes. J Manag Care Spec. 2020;26:600\u20139. https:\/\/doi.org\/10.18553\/jmcp.2020.26.5.600.","DOI":"10.18553\/jmcp.2020.26.5.600"},{"key":"1431_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110230","volume":"196","author":"T Wallace","year":"2023","unstructured":"Wallace T, Heath J, Koebbel C. The impact of flash glucose monitoring on adults with type\u00a01 diabetes\u2019 eating habits and relationship with food. Diabetes Res Clin Pract. 2023;196:110230. https:\/\/doi.org\/10.1016\/j.diabres.2022.110230.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR101","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0419","author":"WH Polonsky","year":"2022","unstructured":"Polonsky WH, Fortmann AL, Soriano EC, Guzman SJ, Funnell MM. The AH-HA! project: transforming group diabetes self-management education through the addition of flash glucose monitoring. Diabetes Technol Ther. 2022. https:\/\/doi.org\/10.1089\/dia.2022.0419.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12902-021-00742-5","volume":"21","author":"DA Rivera-\u00c1vila","year":"2021","unstructured":"Rivera-\u00c1vila DA, Esquivel-Lu AI, Salazar-Lozano CR, Jones K, Doubova SV. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type\u00a02 diabetes. BMC Endocr Disord. 2021;21:79. https:\/\/doi.org\/10.1186\/s12902-021-00742-5.","journal-title":"BMC Endocr Disord"},{"key":"1431_CR103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11892-021-01408-1","volume":"21","author":"TK Oser","year":"2021","unstructured":"Oser TK, Litchman ML, Allen NA, et al. Personal continuous glucose monitoring use among adults with type\u00a02 diabetes: clinical efficacy and economic impacts. Curr Diabetes Rep. 2021;21:49. https:\/\/doi.org\/10.1007\/s11892-021-01408-1.","journal-title":"Curr Diabetes Rep"},{"key":"1431_CR104","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/jendso\/bvab013","volume":"5","author":"RM Bergenstal","year":"2021","unstructured":"Bergenstal RM, Kerr MSD, Roberts GJ, Souto D, Nabutovsky Y, Hirsch IB. Flash CGM is associated with reduced diabetes events and hospitalizations in insulin-treated type\u00a02 diabetes. J Endocr Soc. 2021;5:13. https:\/\/doi.org\/10.1210\/jendso\/bvab013.","journal-title":"J Endocr Soc"},{"key":"1431_CR105","unstructured":"FreeStyle Libre\u00a02 Flash Glucose Monitoring System. Haute Autorite Sante 2020."},{"key":"1431_CR106","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/ppa.s49287","volume":"7","author":"R Miao","year":"2013","unstructured":"Miao R, Wei W, Baser O, Xie L. Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type\u00a02 diabetes treated with insulin glargine. Patient Prefer Adher. 2013;7:951\u201360. https:\/\/doi.org\/10.2147\/ppa.s49287.","journal-title":"Patient Prefer Adher"},{"key":"1431_CR107","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s13300-020-00874-2","volume":"11","author":"R Roussel","year":"2020","unstructured":"Roussel R, Detournay B, Boultif Z, Bahloul A, Teissier C, Charbonnel B. Persistence with basal insulin and frequency of hypoglycemia requiring hospitalization in patients with type\u00a02 diabetes. Diabetes Ther. 2020;11:1861\u201372. https:\/\/doi.org\/10.1007\/s13300-020-00874-2.","journal-title":"Diabetes Ther"},{"key":"1431_CR108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pcd.2018.09.002","volume":"13","author":"I Idris","year":"2019","unstructured":"Idris I, Gulati K, Perez-Nieves M, et al. Associated factors that influenced persistence with basal analog insulin therapy among people with type\u00a02 diabetes: an exploratory analysis from a UK real-world sample. Prim Care Diabetes. 2019;13:106\u201312. https:\/\/doi.org\/10.1016\/j.pcd.2018.09.002.","journal-title":"Prim Care Diabetes"},{"key":"1431_CR109","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2337\/dc21-1304","volume":"44","author":"G Aleppo","year":"2021","unstructured":"Aleppo G, Beck RW, Bailey R, et al. The effect of discontinuing continuous glucose monitoring in adults with type\u00a02 diabetes treated with basal insulin. Diabetes Care. 2021;44:2729\u201337. https:\/\/doi.org\/10.2337\/dc21-1304.","journal-title":"Diabetes Care"},{"key":"1431_CR110","doi-asserted-by":"publisher","first-page":"147916412110213","DOI":"10.1177\/14791641211021374","volume":"18","author":"T Elliott","year":"2021","unstructured":"Elliott T, Beca S, Beharry R, Tsoukas MA, Zarruk A, Abitbol A. The impact of flash glucose monitoring on glycated hemoglobin in type\u00a02 diabetes managed with basal insulin in Canada: a retrospective real-world chart review study. Diabetes Vasc Dis Re. 2021;18:14791641211021374. https:\/\/doi.org\/10.1177\/14791641211021374.","journal-title":"Diabetes Vasc Dis Re"},{"key":"1431_CR111","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/dc09-0586","volume":"32","author":"A Moran","year":"2009","unstructured":"Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32:1626\u201331. https:\/\/doi.org\/10.2337\/dc09-0586.","journal-title":"Diabetes Care"},{"key":"1431_CR112","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1515\/jpem-2019-0484","volume":"33","author":"C Alves","year":"2020","unstructured":"Alves C, Della-Manna T, Albuquerque CTM. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment. J Pediatr Endocrinol Metab. 2020;33:835\u201343. https:\/\/doi.org\/10.1515\/jpem-2019-0484.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1431_CR113","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4239\/wjd.v11.i6.213","volume":"11","author":"L Pozo","year":"2020","unstructured":"Pozo L, Bello F, Mendez Y, Surani S. Cystic fibrosis-related diabetes: the unmet need. World J Diabetes. 2020;11:213\u20137. https:\/\/doi.org\/10.4239\/wjd.v11.i6.213.","journal-title":"World J Diabetes"},{"key":"1431_CR114","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2337\/dc09-1215","volume":"33","author":"P Chamnan","year":"2010","unstructured":"Chamnan P, Shine BSF, Haworth CS, Bilton D, Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care. 2010;33:311\u20136. https:\/\/doi.org\/10.2337\/dc09-1215.","journal-title":"Diabetes Care"},{"key":"1431_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2022.100305","volume":"30","author":"S Kumar","year":"2022","unstructured":"Kumar S, Pallin M, Soldatos G, Teede H. Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic fibrosis: a systematic review. J Clin Transl Endocrinol. 2022;30:100305. https:\/\/doi.org\/10.1016\/j.jcte.2022.100305.","journal-title":"J Clin Transl Endocrinol"},{"key":"1431_CR116","doi-asserted-by":"publisher","unstructured":"Zorron M, Marson FAL, Morcillo AM, et al. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome? J Bras Pneumol 2022;48:202. https:\/\/doi.org\/10.36416\/1806-3756\/e20210307.","DOI":"10.36416\/1806-3756\/e20210307"},{"key":"1431_CR117","doi-asserted-by":"publisher","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","volume":"107","author":"KJ Scully","year":"2021","unstructured":"Scully KJ, Sherwood JS, Martin K, et al. Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis. J Clin Endocrinol Metab. 2021;107:e1444\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgab857.","journal-title":"J Clin Endocrinol Metab"},{"key":"1431_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.07.013","author":"S Kumar","year":"2022","unstructured":"Kumar S, Soldatos G, Ranasinha S, Teede H, Pallin M. Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: a systematic review and meta-analysis. J Cyst Fibros. 2022. https:\/\/doi.org\/10.1016\/j.jcf.2022.07.013.","journal-title":"J Cyst Fibros"},{"key":"1431_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.659728","volume":"9","author":"B Gojsina","year":"2021","unstructured":"Gojsina B, Minic P, Todorovic S, Soldatovic I, Sovtic A. Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis. Front Pediatr. 2021;9: 659728. https:\/\/doi.org\/10.3389\/fped.2021.659728.","journal-title":"Front Pediatr"},{"key":"1431_CR120","unstructured":"UK Cystic Fibrosis Registry. 2021 Annual Data Report. https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2022-10\/CFT_2021-Annual-Data-Report-WEB.pdf, 1.24 CF-related diabetes, 34."},{"key":"1431_CR121","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/dia.2021.0212","volume":"24","author":"T Grace","year":"2022","unstructured":"Grace T, Salyer J. Use of real-time continuous glucose monitoring improves glycemic control and other clinical outcomes in type\u00a02 diabetes patients treated with less intensive therapy. Diabetes Technol Ther. 2022;24:26\u201331. https:\/\/doi.org\/10.1089\/dia.2021.0212.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR122","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR123","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/dia.2021.0494","volume":"24","author":"S Bao","year":"2022","unstructured":"Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type\u00a02 diabetes treated with basal insulin. Diabetes Technol Ther. 2022;24:299\u2013306. https:\/\/doi.org\/10.1089\/dia.2021.0494.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR124","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0034","author":"B Guerci","year":"2023","unstructured":"Guerci B, Levrat-Guillen F, Vicaut E, et al. Reduced acute diabetes events after FreeStyle Libre\u00ae system initiation in people 65 years or older with type\u00a02 diabetes on intensive insulin therapy in France. Diabet Technol Ther. 2023. https:\/\/doi.org\/10.1089\/dia.2023.0034.","journal-title":"Diabet Technol Ther"},{"key":"1431_CR125","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archinternmed.2010.539","volume":"171","author":"MN Munshi","year":"2011","unstructured":"Munshi MN, Segal AR, Suhl E, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171:362\u20134. https:\/\/doi.org\/10.1001\/archinternmed.2010.539.","journal-title":"Arch Intern Med"},{"key":"1431_CR126","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.2337\/dc13-0610","volume":"36","author":"KJ Lipska","year":"2013","unstructured":"Lipska KJ, Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type\u00a02 diabetes. Diabetes Care. 2013;36:3535\u201342. https:\/\/doi.org\/10.2337\/dc13-0610.","journal-title":"Diabetes Care"},{"key":"1431_CR127","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1464-5491.1995.tb00405.x","volume":"12","author":"GS Meneilly","year":"1995","unstructured":"Meneilly GS, Tessier D. Diabetes in the elderly. Diabetic Med. 1995;12:949\u201360. https:\/\/doi.org\/10.1111\/j.1464-5491.1995.tb00405.x.","journal-title":"Diabetic Med"},{"key":"1431_CR128","doi-asserted-by":"publisher","first-page":"M5","DOI":"10.1093\/gerona\/56.1.m5","volume":"56","author":"GS Meneilly","year":"2001","unstructured":"Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol Ser. 2001;56:M5-13. https:\/\/doi.org\/10.1093\/gerona\/56.1.m5.","journal-title":"J Gerontol Ser"},{"key":"1431_CR129","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1111\/j.1464-5491.2012.03681.x","volume":"29","author":"M Sch\u00fctt","year":"2012","unstructured":"Sch\u00fctt M, Fach E-M, Seufert J, et al. Multiple complications and frequent severe hypoglycaemia in \u2018elderly\u2019 and \u2018old\u2019 patients with type\u00a01 diabetes. Diabetic Med. 2012;29:e176\u20139. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03681.x.","journal-title":"Diabetic Med"},{"key":"1431_CR130","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jbmr.3002","volume":"32","author":"M Wallander","year":"2017","unstructured":"Wallander M, Axelsson KF, Nilsson AG, Lundh D, Lorentzon M. Type\u00a02 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort (FRAILCO). J Bone Miner Res. 2017;32:449\u201360. https:\/\/doi.org\/10.1002\/jbmr.3002.","journal-title":"J Bone Miner Res"},{"key":"1431_CR131","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/dom.13769","volume":"21","author":"K Mattishent","year":"2019","unstructured":"Mattishent K, Richardson K, Dhatariya K, Savva GM, Fox C, Loke YK. The effects of hypoglycaemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older individuals: a retrospective cohort study. Diabetes Obes Metab. 2019;21:2076\u201385. https:\/\/doi.org\/10.1111\/dom.13769.","journal-title":"Diabetes Obes Metab"},{"key":"1431_CR132","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bcp.14517","volume":"87","author":"K Mattishent","year":"2021","unstructured":"Mattishent K, Loke YK. Is avoidance of hypoglycaemia a better target than HbA1C in older people with diabetes? Brit J Clin Pharmaco. 2021;87:9\u201311. https:\/\/doi.org\/10.1111\/bcp.14517.","journal-title":"Brit J Clin Pharmaco"},{"key":"1431_CR133","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1016\/s2666-7568(21)00170-7","volume":"2","author":"V Kosjerina","year":"2021","unstructured":"Kosjerina V, Carstensen B, J\u00f8rgensen ME, et al. Discontinuation of diabetes medication in the 10 years before death in Denmark: a register-based study. Lancet Heal Longev. 2021;2:e561\u201370. https:\/\/doi.org\/10.1016\/s2666-7568(21)00170-7.","journal-title":"Lancet Heal Longev"},{"key":"1431_CR134","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.2147\/ppa.s208947","volume":"13","author":"HE Hart","year":"2019","unstructured":"Hart HE, Ditzel K, Rutten GE, et al. De-intensification of blood glucose lowering medication in people identified as being over-treated: a mixed methods study. Patient Prefer Adher. 2019;13:1775\u201383. https:\/\/doi.org\/10.2147\/ppa.s208947.","journal-title":"Patient Prefer Adher"},{"key":"1431_CR135","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/dia.2021.0156","volume":"23","author":"E Selvin","year":"2021","unstructured":"Selvin E, Wang D, Tang O, Minotti M, Echouffo-Tcheugui JB, Coresh J. Glucose patterns in very old adults: a pilot study in a community-based population. Diabetes Technol Ther. 2021;23:737\u201344. https:\/\/doi.org\/10.1089\/dia.2021.0156.","journal-title":"Diabetes Technol Ther"},{"key":"1431_CR136","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2011;7:280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1431_CR137","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/biomedicines10040778","volume":"10","author":"A Athanasaki","year":"2022","unstructured":"Athanasaki A, Melanis K, Tsantzali I, et al. Type\u00a02 diabetes mellitus as a risk factor for Alzheimer\u2019s disease: review and meta-analysis. Biomed. 2022;10:778. https:\/\/doi.org\/10.3390\/biomedicines10040778.","journal-title":"Biomed"},{"key":"1431_CR138","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cger.2020.04.002","volume":"36","author":"A Sinclair","year":"2020","unstructured":"Sinclair A, Abdelhafiz A. Cognitive dysfunction in older adults with type\u00a02 diabetes: links, risks, and clinical implications. Clin Geriatr Med. 2020;36:407\u201317. https:\/\/doi.org\/10.1016\/j.cger.2020.04.002.","journal-title":"Clin Geriatr Med"},{"key":"1431_CR139","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.diabet.2014.02.002","volume":"40","author":"L Bordier","year":"2014","unstructured":"Bordier L, Doucet J, Boudet J, Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab. 2014;40:331\u20137. https:\/\/doi.org\/10.1016\/j.diabet.2014.02.002.","journal-title":"Diabetes Metab"},{"key":"1431_CR140","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc10-2424","volume":"34","author":"N Laiteerapong","year":"2011","unstructured":"Laiteerapong N, Karter AJ, Liu JY, et al. Correlates of quality of life in older adults with diabetes. Diabetes Care. 2011;34:1749\u201353. https:\/\/doi.org\/10.2337\/dc10-2424.","journal-title":"Diabetes Care"},{"key":"1431_CR141","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1753944715594528","volume":"9","author":"F Angeli","year":"2015","unstructured":"Angeli F, Reboldi G, Poltronieri C, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis. 2015;9:412\u201324. https:\/\/doi.org\/10.1177\/1753944715594528.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1431_CR142","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26714","volume":"14","author":"D Vedantam","year":"2022","unstructured":"Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-induced hyperglycemia: consequences and management. Cureus. 2022;14:e26714. https:\/\/doi.org\/10.7759\/cureus.26714.","journal-title":"Cureus"},{"key":"1431_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.901815","volume":"13","author":"R Marfella","year":"2022","unstructured":"Marfella R, Federici M, Paolisso G. Editorial: hyperglycemia and coronary artery diseases: physio-pathological findings and therapeutic implications. Front Pharmacol. 2022;13: 901815. https:\/\/doi.org\/10.3389\/fphar.2022.901815.","journal-title":"Front Pharmacol"},{"key":"1431_CR144","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/oxfordjournals.eurheartj.a015067","volume":"17","author":"K Malmberg","year":"1996","unstructured":"Malmberg K, Ryd\u00e9n L, Hamstent A, Herlitz J, Waldenstr\u00f6m A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J. 1996;17:1337\u201344. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015067.","journal-title":"Eur Heart J"},{"key":"1431_CR145","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s2213-8587(14)70088-9","volume":"2","author":"V Ritsinger","year":"2014","unstructured":"Ritsinger V, Malmberg K, M\u00e5rtensson A, Ryd\u00e9n L, Wedel H, Norhammar A. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial. Lancet Diabetes Endocrinol. 2014;2:627\u201333. https:\/\/doi.org\/10.1016\/s2213-8587(14)70088-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1431_CR146","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","volume":"26","author":"K Malmberg","year":"2005","unstructured":"Malmberg K, Ryd\u00e9n L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehi199.","journal-title":"Eur Heart J"},{"key":"1431_CR147","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1136\/bmj.f4533","volume":"347","author":"A Goto","year":"2013","unstructured":"Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013;347:4533. https:\/\/doi.org\/10.1136\/bmj.f4533.","journal-title":"BMJ"},{"key":"1431_CR148","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/diacare.28.2.355","volume":"28","author":"BM Kissela","year":"2005","unstructured":"Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes. Diabetes Care. 2005;28:355\u20139. https:\/\/doi.org\/10.2337\/diacare.28.2.355.","journal-title":"Diabetes Care"},{"key":"1431_CR149","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/wnl.59.5.669","volume":"59","author":"A Bruno","year":"2002","unstructured":"Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology. 2002;59:669\u201374. https:\/\/doi.org\/10.1212\/wnl.59.5.669.","journal-title":"Neurology"},{"key":"1431_CR150","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/hs1001.096194","volume":"32","author":"SE Capes","year":"2001","unstructured":"Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke. 2001;32:2426\u201332. https:\/\/doi.org\/10.1161\/hs1001.096194.","journal-title":"Stroke"},{"key":"1431_CR151","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/nyas.14583","volume":"1495","author":"MJ Krinock","year":"2021","unstructured":"Krinock MJ, Singhal NS. Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Ann N Y Acad Sci. 2021;1495:78\u201398. https:\/\/doi.org\/10.1111\/nyas.14583.","journal-title":"Ann N Y Acad Sci"},{"key":"1431_CR152","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1161\/str.0000000000000358","volume":"52","author":"ML Rodgers","year":"2021","unstructured":"Rodgers ML, Fox E, Abdelhak T, et al. Care of the patient with acute ischemic stroke (Endovascular\/Intensive Care Unit-Postinterventional Therapy): update to 2009 comprehensive nursing care scientific statement: a scientific statement from the American Heart Association. Stroke. 2021;52:e198-210. https:\/\/doi.org\/10.1161\/str.0000000000000358.","journal-title":"Stroke"},{"key":"1431_CR153","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.4239\/wjd.v12.i7.1010","volume":"12","author":"C Yim","year":"2021","unstructured":"Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. World J Diabetes. 2021;12:1010\u201325. https:\/\/doi.org\/10.4239\/wjd.v12.i7.1010.","journal-title":"World J Diabetes"},{"key":"1431_CR154","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.critrevonc.2017.03.007","volume":"113","author":"MC Gerards","year":"2017","unstructured":"Gerards MC, van der Velden DL, Baars JW, et al. Impact of hyperglycemia on the efficacy of chemotherapy\u2014a systematic review of preclinical studies. Crit Rev Oncol Hemat. 2017;113:235\u201341. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.007.","journal-title":"Crit Rev Oncol Hemat"},{"key":"1431_CR155","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1097\/ccm.0b013e318181039a","volume":"36","author":"M Egi","year":"2008","unstructured":"Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249\u201355. https:\/\/doi.org\/10.1097\/ccm.0b013e318181039a.","journal-title":"Crit Care Med"},{"key":"1431_CR156","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/ccm.0b013e3181cc4be9","volume":"38","author":"J Hermanides","year":"2010","unstructured":"Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, DeVries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838\u201342. https:\/\/doi.org\/10.1097\/ccm.0b013e3181cc4be9.","journal-title":"Crit Care Med"},{"key":"1431_CR157","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4103\/1119-3077.187323","volume":"19","author":"J Yang","year":"2016","unstructured":"Yang J, Jia B, Qiao Y, Chen W, Qi X. Variations of blood glucose in cancer patients during chemotherapy. Niger J Clin Pract. 2016;19:704. https:\/\/doi.org\/10.4103\/1119-3077.187323.","journal-title":"Niger J Clin Pract"},{"key":"1431_CR158","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1086\/501830","volume":"22","author":"R Latham","year":"2001","unstructured":"Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607\u201312. https:\/\/doi.org\/10.1086\/501830.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1431_CR159","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/ice.2015.249","volume":"37","author":"ET Martin","year":"2016","unstructured":"Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37:88\u201399. https:\/\/doi.org\/10.1017\/ice.2015.249.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1431_CR160","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jdiacomp.2015.07.027","volume":"29","author":"L Buehler","year":"2015","unstructured":"Buehler L, Fayfman M, Alexopoulos A-S, et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complicat. 2015;29:1177\u201382. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.07.027.","journal-title":"J Diabetes Complicat"},{"key":"1431_CR161","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1177\/1932296817704445","volume":"11","author":"KJ Ruedy","year":"2017","unstructured":"Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, DIAMOND Study Group. Continuous glucose monitoring in older adults with type\u00a01 and type\u00a02 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11:1138\u201346. https:\/\/doi.org\/10.1177\/1932296817704445.","journal-title":"J Diabetes Sci Technol"},{"key":"1431_CR162","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4239\/wjd.v9.i7.132","volume":"9","author":"V Gomes","year":"2018","unstructured":"Gomes V, Ferreira F, Guerra J, Bugalho MJ. New-onset diabetes after kidney transplantation: incidence and associated factors. World J Diabetes. 2018;9:132\u20137. https:\/\/doi.org\/10.4239\/wjd.v9.i7.132.","journal-title":"World J Diabetes"},{"key":"1431_CR163","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/tp.0000000000003647","volume":"106","author":"AR Vest","year":"2022","unstructured":"Vest AR, Cherikh WS, Noreen SM, Stehlik J, Khush KK. New-onset diabetes mellitus after adult heart transplantation and the risk of renal dysfunction or mortality. Transplantation. 2022;106:178\u201387. https:\/\/doi.org\/10.1097\/tp.0000000000003647.","journal-title":"Transplantation"},{"key":"1431_CR164","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.tp.0000069952.49242.3e","volume":"75","author":"J Davidson","year":"2003","unstructured":"Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation. 2003;75:3\u201324. https:\/\/doi.org\/10.1097\/01.tp.0000069952.49242.3e.","journal-title":"Transplantation"},{"key":"1431_CR165","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","volume":"62","author":"FG Cosio","year":"2002","unstructured":"Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV impact of post-transplant diabetes. Kidney Int. 2002;62:1440\u20136. https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid582.x.","journal-title":"Kidney Int"},{"key":"1431_CR166","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2018","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2018;42: 181444. https:\/\/doi.org\/10.2337\/dc18-1444.","journal-title":"Diabetes Care"},{"key":"1431_CR167","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type\u00a02 diabetes. Diabetes Care. 2018;41: 181131. https:\/\/doi.org\/10.2337\/dc18-1131.","journal-title":"Diabetes Care"},{"key":"1431_CR168","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.diabres.2010.06.001","volume":"90","author":"E Sobngwi","year":"2010","unstructured":"Sobngwi E, Ashuntantang G, Ndounia E, et al. Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis. Diabetes Res Clin Pract. 2010;90:22\u20135. https:\/\/doi.org\/10.1016\/j.diabres.2010.06.001.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR169","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","volume":"107","author":"M Joubert","year":"2015","unstructured":"Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study. Diabetes Res Clin Pract. 2015;107:348\u201354. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.026.","journal-title":"Diabetes Res Clin Pract"},{"key":"1431_CR170","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:181581. https:\/\/doi.org\/10.2337\/dc18-1581.","journal-title":"Diabetes Care"},{"key":"1431_CR171","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","volume":"41","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev. 2020;41:756\u201374. https:\/\/doi.org\/10.1210\/endrev\/bnaa017.","journal-title":"Endocr Rev"},{"key":"1431_CR172","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14638","author":"F Gomez-Peralta","year":"2022","unstructured":"Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami-Merhar B, Seibold A. Understanding the clinical implications of differences between GMI and HbA1c. Diabetes Obes Metab. 2022. https:\/\/doi.org\/10.1111\/dom.14638.","journal-title":"Diabetes Obes Metab"},{"key":"1431_CR173","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s2213-8587(20)30406-x","volume":"9","author":"HR Murphy","year":"2021","unstructured":"Murphy HR, Howgate C, O\u2019Keefe J, et al. Characteristics and outcomes of pregnant women with type\u00a01 or type\u00a02 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021;9:153\u201364. https:\/\/doi.org\/10.1016\/s2213-8587(20)30406-x.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1431_CR174","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/bmj.38043.583160.ee","volume":"328","author":"IM Evers","year":"2004","unstructured":"Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type\u00a01 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915. https:\/\/doi.org\/10.1136\/bmj.38043.583160.ee.","journal-title":"BMJ"},{"key":"1431_CR175","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4239\/wjd.v8.i12.489","volume":"8","author":"AM Dirar","year":"2017","unstructured":"Dirar AM, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8:489\u2013511. https:\/\/doi.org\/10.4239\/wjd.v8.i12.489.","journal-title":"World J Diabetes"},{"key":"1431_CR176","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12020-021-02787-x","volume":"74","author":"S-Y Shen","year":"2021","unstructured":"Shen S-Y, \u017durauskien\u0117 J, Wei D-M, et al. Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes. Endocrine. 2021;74:290\u20139. https:\/\/doi.org\/10.1007\/s12020-021-02787-x.","journal-title":"Endocrine"},{"key":"1431_CR177","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/dc18-2212","volume":"42","author":"GR Law","year":"2019","unstructured":"Law GR, Alnaji A, Alrefaii L, et al. Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care. 2019;42:810\u20135. https:\/\/doi.org\/10.2337\/dc18-2212.","journal-title":"Diabetes Care"},{"key":"1431_CR178","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.3390\/ijerph18073402","volume":"18","author":"M G\u00e1borov\u00e1","year":"2021","unstructured":"G\u00e1borov\u00e1 M, Doni\u010dov\u00e1 V, Ba\u010dov\u00e1 I, et al. Glycaemic variability and risk factors of pregnant women with and without gestational diabetes mellitus measured by continuous glucose monitoring. Int J Environ Res Public Health. 2021;18:3402. https:\/\/doi.org\/10.3390\/ijerph18073402.","journal-title":"Int J Environ Res Public Health"},{"key":"1431_CR179","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/jcm11102932","volume":"11","author":"A Majewska","year":"2022","unstructured":"Majewska A, Stanirowski PJ, Wielgo\u015b M, Bomba-Opo\u0144 D. Efficacy of continuous glucose monitoring on glycaemic control in pregnant women with gestational diabetes mellitus\u2014a systematic review. J Clin Med. 2022;11:2932. https:\/\/doi.org\/10.3390\/jcm11102932.","journal-title":"J Clin Med"},{"key":"1431_CR180","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14703","volume":"39","author":"RM Garc\u00eda-Moreno","year":"2022","unstructured":"Garc\u00eda-Moreno RM, Ben\u00edtez-Valderrama P, Barquiel B, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022;39:e14703. https:\/\/doi.org\/10.1111\/dme.14703.","journal-title":"Diabet Med"},{"key":"1431_CR181","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/aje\/kwk071","volume":"165","author":"T Harder","year":"2007","unstructured":"Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A. Birth weight and subsequent risk of type\u00a02 diabetes: a meta-analysis. Am J Epidemiol. 2007;165:849\u201357. https:\/\/doi.org\/10.1093\/aje\/kwk071.","journal-title":"Am J Epidemiol"},{"key":"1431_CR182","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1056\/nejmoa1803527","volume":"379","author":"M Geserick","year":"2018","unstructured":"Geserick M, Vogel M, Gausche R, et al. Acceleration of BMI in early childhood and risk of sustained obesity. New Engl J Med. 2018;379:1303\u201312. https:\/\/doi.org\/10.1056\/nejmoa1803527.","journal-title":"New Engl J Med"},{"key":"1431_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100289","volume":"27","author":"R Oxman","year":"2022","unstructured":"Oxman R, Roe AH, Jagdeesh U, Putman MS. Gestational and pregestational diabetes in pregnant women with cystic fibrosis. J Clin Transl Endocrinol. 2022;27: 100289. https:\/\/doi.org\/10.1016\/j.jcte.2021.100289.","journal-title":"J Clin Transl Endocrinol"},{"key":"1431_CR184","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/1471-0528.16423","volume":"127","author":"A Ashcroft","year":"2020","unstructured":"Ashcroft A, Chapman S, Mackillop L. The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study. Bjog Int J Obstetrics Gynaecol. 2020;127:1696\u2013703. https:\/\/doi.org\/10.1111\/1471-0528.16423.","journal-title":"Bjog Int J Obstetrics Gynaecol"},{"key":"1431_CR185","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.2337\/dc07-0500","volume":"30","author":"HR Murphy","year":"2007","unstructured":"Murphy HR, Rayman G, Duffield K, et al. Changes in the glycemic profiles of women with type\u00a01 and type\u00a02 diabetes during pregnancy. Diabetes Care. 2007;30:2785\u201391. https:\/\/doi.org\/10.2337\/dc07-0500.","journal-title":"Diabetes Care"},{"key":"1431_CR186","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/s0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type\u00a01 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390:2347\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(17)32400-5.","journal-title":"Lancet"},{"key":"1431_CR187","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.2337\/dc22-0078","volume":"45","author":"EM Scott","year":"2022","unstructured":"Scott EM, Murphy HR, Kristensen KH, et al. Continuous glucose monitoring metrics and birth weight: informing management of type\u00a01 diabetes throughout pregnancy. Diabetes Care. 2022;45:1724\u201334. https:\/\/doi.org\/10.2337\/dc22-0078.","journal-title":"Diabetes Care"},{"key":"1431_CR188","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","volume":"62","author":"K Kristensen","year":"2019","unstructured":"Kristensen K, \u00d6gge LE, Sengpiel V, et al. Continuous glucose monitoring in pregnant women with type\u00a01 diabetes: an observational cohort study of 186 pregnancies. Diabetologia. 2019;62:1143\u201353. https:\/\/doi.org\/10.1007\/s00125-019-4850-0.","journal-title":"Diabetologia"},{"key":"1431_CR189","doi-asserted-by":"publisher","DOI":"10.1055\/a-1904-9279","author":"MF Bartal","year":"2022","unstructured":"Bartal MF, Cornthwaite JA, Ghafir D, et al. Time in range and pregnancy outcomes in people with diabetes using continuous glucose monitoring. Am J Perinat. 2022. https:\/\/doi.org\/10.1055\/a-1904-9279.","journal-title":"Am J Perinat"},{"key":"1431_CR190","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/09513590.2021.1993814","volume":"37","author":"N Dori-Dayan","year":"2021","unstructured":"Dori-Dayan N, Cukierman-Yaffe T, Kedar N, et al. Maternal glucose variability during pregnancy & birthweight percentile in women with pre-gestational diabetes. Gynecol Endocrinol. 2021;37:1116\u201320. https:\/\/doi.org\/10.1080\/09513590.2021.1993814.","journal-title":"Gynecol Endocrinol"},{"key":"1431_CR191","doi-asserted-by":"publisher","first-page":"147916412211368","DOI":"10.1177\/14791641221136837","volume":"19","author":"M Lemaitre","year":"2022","unstructured":"Lemaitre M, Faiz K, Baudoux F, Subtil D, Vambergue A. Intermittently scanned continuous glucose monitoring is associated with lower spontaneous abortion rate compared with conventional blood glucose monitoring in pregnant women with type\u00a01 diabetes: an observational study. Diabetes Vasc Dis Res. 2022;19:14791641221136836. https:\/\/doi.org\/10.1177\/14791641221136837.","journal-title":"Diabetes Vasc Dis Res"},{"key":"1431_CR192","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041486","volume":"11","author":"A Majewska","year":"2021","unstructured":"Majewska A, Stanirowski P, Wielgo\u015b M, Bomba-Opo\u0144 D. Flash glucose monitoring in gestational diabetes mellitus: study protocol for a randomised controlled trial. BMJ Open. 2021;11:e041486. https:\/\/doi.org\/10.1136\/bmjopen-2020-041486.","journal-title":"BMJ Open"},{"key":"1431_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13300-021-01132-9","volume":"2","author":"P Choudhary","year":"2021","unstructured":"Choudhary P, Bellido V, Graner M, et al. The challenge of sustainable access to telemonitoring tools for people with diabetes in Europe: lessons from COVID-19 and beyond. Diabetes Ther. 2021;2:1\u201317. https:\/\/doi.org\/10.1007\/s13300-021-01132-9.","journal-title":"Diabetes Ther"},{"key":"1431_CR194","unstructured":"Commission E. Benchmarking deployment of eHealth among general practitioners. 2018."},{"key":"1431_CR195","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s13300-021-01114-x","volume":"12","author":"T Danne","year":"2021","unstructured":"Danne T, Limbert C, Domingo MP, et al. Telemonitoring, telemedicine and time in range during the pandemic: paradigm change for diabetes risk management in the post-COVID future. Diabetes Ther. 2021;12:2289\u2013310. https:\/\/doi.org\/10.1007\/s13300-021-01114-x.","journal-title":"Diabetes Ther"},{"key":"1431_CR196","doi-asserted-by":"publisher","first-page":"309","DOI":"10.24875\/gmm.m21000563","volume":"157","author":"R Silva-Tinoco","year":"2021","unstructured":"Silva-Tinoco R, de la Torre-Salda\u00f1a V. The imperious need for telemedicine for the care of diabetes during the COVID-19 pandemic. A comprehensive approach study. Gac Med Mex. 2021;157:309\u201312. https:\/\/doi.org\/10.24875\/gmm.m21000563.","journal-title":"Gac Med Mex"},{"key":"1431_CR197","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/ijerph20031963","volume":"20","author":"K Pogorzelska","year":"2023","unstructured":"Pogorzelska K, Marcinowicz L, Chlabicz S. A qualitative study of primary care physicians\u2019 experiences with telemedicine during the COVID-19 pandemic in North-Eastern Poland. Int J Environ Res Public Health. 2023;20:1963. https:\/\/doi.org\/10.3390\/ijerph20031963.","journal-title":"Int J Environ Res Public Health"},{"key":"1431_CR198","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066871","volume":"12","author":"M-E Poitras","year":"2022","unstructured":"Poitras M-E, Poirier M-D, Couturier Y, et al. Chronic conditions patient\u2019s perception of post-COVID-19 pandemic teleconsulting continuation in primary care clinics: a qualitative descriptive study. BMJ Open. 2022;12:e066871. https:\/\/doi.org\/10.1136\/bmjopen-2022-066871.","journal-title":"BMJ Open"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-023-01431-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T06:10:37Z","timestamp":1687846237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-023-01431-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":198,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s13300-023-01431-3","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}